Saturday, 28 January 2012

Tom Danielson Improves his Vision with Visian ICLs at Icon LASIK in Denver, Colorado

Denver, CO (Vocus/PRWEB) January 05, 2011

Tom Danielson, a professional cyclist for the American Garmin-Cervelo team, recently had eye surgery at Icon LASIK in Denver, Colorado. Tom suffered from extremely dry eyes throughout his career and was forced to wear contact lenses during his long training rides and during races. Tom?s Rx went from a -4.75 to 20/20 one day post op and 20/10 two weeks post op!


Tom Danielson?s bio is available at TomDanielson.com or follow Tom @tomdanielson


The independent ophthalmologists and optometrists for Icon LASIK determined that Tom was not a good candidate for traditional LASIK surgery. A majority of the population in Colorado (even if you have an astigmatism) can receive LASIK. However, if you are not eligible for LASIK the ICL is a great option. After receiving an ICL vision is typical 20/20 or better and there are very few complications. The Visian ICL is Icon?s lens of choice for its Colorado patients due to the unique Collamer? material.


Visian ICL surgery is an ?additive? procedure that does not involve removing tissue or irreversibly reshaping the eye. As such, it keeps the eye structure in-tact for any future surgical needs such as cataract treatment. While the Visian ICL is intended to provide permanent vision correction, the lens can be removed if necessary to restore the eye to its pre-implant state. LASIK, in contrast, is a ?reductive? procedure that permanently reshapes the eye by removing corneal tissue. More than 500 surgeons at leading vision correction centers across the US have been trained and certified to perform the implant procedure.


The Visian ICL earned the CE Mark for use in Europe, where it has been available commercially for more than a decade. The lens is currently sold in more than 40 countries and has been implanted during more than 150,000 procedures worldwide.


Icon LASIK's independent doctors treat many cyclists, not just for LASIK but also for common conditions such as dry eyes. Icon's doctors have the benefit of seeing thousands of patients every year. This experience, combined with leading technology, ensures every patient gets the best custom care possible.


Patients can schedule a free LASIK consultation by calling 720-524-1001 or by visiting IconDenver.com.


Icon LASIK?s independent ophthalmologists and optometrists are committed to providing world-class vision care to thousands of patients each year at its offices in Denver, Grand Junction, and Loveland.


In addition to using the Visian ICL, Icon LASIK owns the most advanced custom laser systems available in the U.S., including the VISX Star4 Wavefront Laser, the NIDEK EC-5000, and the IntraLase bladeless LASIK system. Icon LASIK offers free LASIK consultations at any of its three locations.


The cost of the Visian ICL is $ 4300 per eye. LASIK starts at just $ 499 per eye and financing is with approved credit for 0%, or $ 0 down, or no payments for 12 months. Because of the affordable financing, more LASIK patients are able to take advantage of Icon's experience and technology. To schedule a free Icon LASIK consultation, visit icondenver.com or call 720.524.1001.


About Icon LASIK ? Denver, Grand Junction, & Loveland Locations


With over 20 years of general eye and refractive experience, the doctors and staff at the Icon LASIK clinics are fully equipped with the latest custom laser technology. Tom Danielson joins Hall of Fame quarterback and Denver legend John Elway in the ranks of athletes who have selected Icon LASIK for laser vision correction.


Icon LASIK has three locations in Colorado:


Icon LASIK Denver, 3900 East Mexico Ave, Suite 102, Denver, CO 80210
Icon LASIK Loveland, 3553 Clydesdale Pkwy, Suite 100, Loveland, CO 80538.
Icon LASIK 120 West Park Drive, Unit 108, Grand Junction, CO 81505.

Icon LASIK is a registered trademark. VISX and Star4 are trademarks of VISX Inc. NIDEK is a trademark of NIDEK Inc. Visian ICL is a trademark of Staar Surgical.


# # #





No comments:

Post a Comment